ESMO China Voice | Dr. Cheng Huang & Dr. Rongbo Lin: Global First Evidence Shows IV IPCA Outperforms Oral Morphine for Severe Cancer Pain, Potentially Changing Guidelines and Transforming Pain Management

ESMO China Voice | Dr. Cheng Huang & Dr. Rongbo Lin: Global First Evidence Shows IV IPCA Outperforms Oral Morphine for Severe Cancer Pain, Potentially Changing Guidelines and Transforming Pain Management

The 2024 European Society for Medical Oncology (ESMO) Annual Meeting was held in Barcelona, Spain. A Phase III randomized controlled trial (SYLT-021), led by Dr. Rongbo Lin’s team from the Department of Gastrointestinal Oncology, Fujian Cancer Hospital, was selected as one of six Proffered Paper oral presentations in the palliative care session. This study compared hydromorphone intravenous patient-controlled analgesia (IPCA) with oral morphine for severe cancer pain management.
Addressing Hemorrhagic Cystitis in HCT: Insights from Dr. Simone Cesaro on BK Virus Surveillance and Clinical Practice Gaps

Addressing Hemorrhagic Cystitis in HCT: Insights from Dr. Simone Cesaro on BK Virus Surveillance and Clinical Practice Gaps

In this exclusive interview with Infectious Diseases Frontier, Professor Simone Cesaro, a leading expert in pediatric hematology and stem cell transplantation, shares his perspectives on the management of BK polyomavirus-associated hemorrhagic cystitis (HC) following hematopoietic cell transplantation (HCT). Drawing from the findings of a recent EBMT survey, he discusses the clinical implications of passive surveillance strategies, platelet transfusion thresholds, and the urgent need for consensus guidelines to support transplant centers across Europe. His insights underscore the importance of early intervention and standardization in addressing this often-overlooked complication.